Document Detail

Treatment of neuroblastoma with human natural antibodies.
MedLine Citation:
PMID:  18558369     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: The response data in patients with relapsed high-risk neuroblastoma justify the further evaluation of this immunotherapeutic approach. For this purpose a standardized pharmaceutical product generated by screening and pooling the plasma of selected blood donors would be of benefit.
Rudolf Erttmann
Related Documents :
215529 - Differences in ebv antibody titres of patients with nasopharyngeal carcinoma originatin...
21986769 - Bladder dysfunction and parkinsonism: current pathophysiological understanding and mana...
8168279 - Importance of serum anticardiolipin antibody levels in coronary heart disease.
19705119 - Autoantibodies in silicosis patients and in silica-exposed individuals.
7121659 - Antirifampicin antibodies in acute rifampicin-associated renal failure.
6327829 - Diagnosis of pertussis.
10973599 - Visual feedback has differential effects on reaching movements in parkinson's and alzhe...
25080509 - Hypothermic cardiopulmonary bypass without exchange transfusion in sickle-cell patients...
18794219 - Evidence of increased motoneuron excitability in stroke patients without clinical spast...
Publication Detail:
Type:  Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article     Date:  2008-04-15
Journal Detail:
Title:  Autoimmunity reviews     Volume:  7     ISSN:  1568-9972     ISO Abbreviation:  Autoimmun Rev     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-18     Completed Date:  2008-08-26     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  101128967     Medline TA:  Autoimmun Rev     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  496-500     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Neoplasm / blood,  therapeutic use*
Child, Preschool
Cytotoxicity, Immunologic
Immunoglobulin M / immunology,  therapeutic use
Neuroblastoma / drug therapy*,  immunology,  pathology
Reg. No./Substance:
0/Antibodies, Neoplasm; 0/Immunoglobulin M

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
Next Document:  Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.